Table: Hisamitsu -2015/16 group results
Apr 8 (Reuters)-
Hisamitsu Pharmaceutical Co Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Feb 29, 2016 Feb 28, 2015 Feb 28, 2017 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 161.85 156.74 155.00 79.80
(+3.3 pct) (+4.1 pct) (-4.2 pct) (-3.2 pct)
Operating 27.73 20.53 28.00 11.60
(+35.1 pct) (+7.3 pct) (+1.0 pct) (-20.1 pct)
Recurring 28.01 28.49 29.00 12.20
(-1.7 pct) (-1.5 pct) (+3.5 pct) (-16.6 pct)
Net 17.78 18.78
(-5.3 pct) (-12.0 pct)
Net 19.40 8.70
(+9.1 pct) (-7.2 pct)
EPS 208.81 yen 219.28 yen 227.79 yen 102.15 yen
EPS Diluted 208.76 yen
Ann Div 81.00 yen 80.00 yen 81.00 yen
-Q2 Div 40.00 yen 37.50 yen 40.50 yen
-Q4 Div 41.00 yen 42.50 yen 40.50 yen
NOTE - Hisamitsu Pharmaceutical Co Inc.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on Hisamitsu Pharmaceutical Co
See all newsTable: Hisamitsu -2025/26 group results
Table: Hisamitsu -2025/26 parent results
Brief: Hisamitsu Pharmaceutical Co Inc - To Retire Treasury Shares Worth 6.34% Of Outstanding Stock On May 12
Brief: Hisamitsu Pharmaceutical Co Inc - Tender Offer Of Company By Taiyo Kosan Successfully Completed
Japan's Hisamitsu Pharmaceutical plans $2.55 billion MBO